200,000+ products from a single source!
sales@angenechem.com
Home > Indoles and Oxindole > 121679-13-8
CAS No: 121679-13-8 Catalog No: AG0015K1 MDL No:MFCD00866221
Title | Journal |
---|---|
Naratriptan mitigates CGRP1-associated motor neuron degeneration caused by an expanded polyglutamine repeat tract. | Nature medicine 20121001 |
Differential effects of calcitonin gene-related peptide receptor blockade by olcegepant on mechanical allodynia induced by ligation of the infraorbital nerve vs the sciatic nerve in the rat. | Pain 20120901 |
Challenges in the simultaneous quantitation of sumatriptan and naproxen in human plasma: application to a bioequivalence study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120801 |
[Extensive mesenteric ischemia related to naratriptan overuse associated with grapefruit juice absorption]. | Annales francaises d'anesthesie et de reanimation 20120501 |
Italian guidelines for primary headaches: 2012 revised version. | The journal of headache and pain 20120501 |
[Pediatric poisoning with triptans: review of cases in the Lille poison center between 2000 and 2010]. | Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 20120301 |
Spinal trigeminal neurons demonstrate an increase in responses to dural electrical stimulation in the orofacial formalin test. | The journal of headache and pain 20120101 |
Migraine-like headache in a patient with complement 1 inhibitor deficient hereditary angioedema. | Journal of Korean medical science 20120101 |
Subcutaneous delivery of sumatriptan in the treatment of migraine and primary headache. | Patient preference and adherence 20120101 |
Headache in pregnancy: a nuisance or a new sense? | Obstetrics and gynecology international 20120101 |
Reduction of current migraine headache pain following neck massage and spinal manipulation. | International journal of therapeutic massage & bodywork 20120101 |
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan. | The journal of headache and pain 20111201 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
Quantitative analysis of eletriptan in human plasma by HPLC-MS/MS and its application to pharmacokinetic study. | Analytical and bioanalytical chemistry 20111101 |
Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. | Pain 20111001 |
Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register. | The journal of headache and pain 20110801 |
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? | The journal of headache and pain 20110801 |
Guidelines on the diagnosis and the current management of headache and related disorders. | Annals of Indian Academy of Neurology 20110701 |
Optimal balance of efficacy and tolerability of oral triptans and telcagepant: a review and a clinical comment. | The journal of headache and pain 20110601 |
Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people. | Cephalalgia : an international journal of headache 20110601 |
Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20110501 |
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine. | The journal of headache and pain 20110401 |
Self-medication of migraine and tension-type headache: summary of the evidence-based recommendations of the Deutsche Migräne und Kopfschmerzgesellschaft (DMKG), the Deutsche Gesellschaft für Neurologie (DGN), the Österreichische Kopfschmerzgesellschaft (ÖKSG) and the Schweizerische Kopfwehgesellschaft (SKG). | The journal of headache and pain 20110401 |
Rizatriptan reduces vestibular-induced motion sickness in migraineurs. | The journal of headache and pain 20110201 |
Why pharmacokinetic differences among oral triptans have little clinical importance: a comment. | The journal of headache and pain 20110201 |
Acute migraine therapy: new drugs and new approaches. | Current treatment options in neurology 20110201 |
Development and validation of a sensitive and rapid method to determine naratriptan in human plasma by LC-ESI-MS-MS: application to a bioequivalence study. | Journal of chromatographic science 20110201 |
Frovatriptan for prophylactic treatment of cluster headache: lessons for future trial design. | Headache 20110101 |
IL-1β stimulates COX-2 dependent PGE₂ synthesis and CGRP release in rat trigeminal ganglia cells. | PloS one 20110101 |
Migraine attacks the Basal Ganglia. | Molecular pain 20110101 |
The use of triptans for pediatric migraines. | Paediatric drugs 20101201 |
Prevention and treatment of menstrual migraine. | Drugs 20101001 |
The natural diatomite from caldiran-van (Turkey): electroanalytical application to antimigraine compound naratriptan at modified carbon paste electrode. | Combinatorial chemistry & high throughput screening 20100901 |
Triptans for the management of migraine. | Drugs 20100820 |
Voltammetric behavior of naratriptan and its determination in tablets. | Talanta 20100715 |
Safety of triptans for migraine headaches during pregnancy and breastfeeding. | Canadian family physician Medecin de famille canadien 20100601 |
Drug dependence associated with triptans and ergot derivatives: a case/non-case study. | European journal of clinical pharmacology 20100401 |
Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study. | Headache 20100401 |
Frovatriptan is Effective and Well Tolerated in Korean Migraineurs: A Double-Blind, Randomized, Placebo-Controlled Trial. | Journal of clinical neurology (Seoul, Korea) 20100301 |
Pure naratriptan-induced ischemic colitis: a case report. | The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 20100301 |
Development and Validation of HPTLC Method for the Estimation of Rizatriptan Benzoate in Bulk and Tablets. | Indian journal of pharmaceutical sciences 20100101 |
Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance. | Current cardiology reviews 20090801 |
Optimized method for the determination of itopride in human plasma by high-performance liquid chromatography with fluorimetric detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090315 |
Clinical aspects of perimenstrual headaches. | Current pain and headache reports 20090201 |
Individual triptan selection in migraine attack therapy. | Recent patents on CNS drug discovery 20090101 |
Obsessive-compulsive disorder and related disorders: a comprehensive survey. | Annals of general psychiatry 20090101 |
Triptans and troponin: a case report. | Orphanet journal of rare diseases 20090101 |
The safety of sumatriptan and naratriptan in pregnancy: what have we learned? | Headache 20090101 |
Migraine: an overview. | The open neurology journal 20090101 |
Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life. | Patient preference and adherence 20090101 |
Halide salts of antimigraine agents eletriptan and naratriptan. | Acta crystallographica. Section C, Crystal structure communications 20081201 |
Current migraine management - patient acceptability and future approaches. | Neuropsychiatric disease and treatment 20081201 |
Prophylaxis of migraine: general principles and patient acceptance. | Neuropsychiatric disease and treatment 20081201 |
Optimizing prophylactic treatment of migraine: Subtypes and patient matching. | Therapeutics and clinical risk management 20081001 |
Prediction of attack frequency in migraine treatment. | Cephalalgia : an international journal of headache 20080801 |
Maximum effect of triptans in migraine? A comment. | Cephalalgia : an international journal of headache 20080701 |
Indolealkylamines: biotransformations and potential drug-drug interactions. | The AAPS journal 20080601 |
Acute treatment and prevention of menstrually related migraine headache: evidence-based review. | Neurology 20080422 |
Use of 5-HT1 agonists in pregnancy. | The Annals of pharmacotherapy 20080401 |
Meta-analysis of the efficacy and safety of zolmitriptan in the acute treatment of migraine. | Headache 20080201 |
Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. | The journal of headache and pain 20080201 |
Triptans in pregnancy. | Therapeutic drug monitoring 20080201 |
Review of frovatriptan in the treatment of migraine. | Neuropsychiatric disease and treatment 20080201 |
Triptan drugs, natural killer cell cytotoxicity, and neutrophils pro-matrix metalloproteinase-9 secretion. | Headache 20080101 |
Sumatriptan inhibits synaptic transmission in the rat midbrain periaqueductal grey. | Molecular pain 20080101 |
Temporary confusion depending on the usage of naratriptan. | The journal of headache and pain 20071201 |
Almotriptan in the treatment of migraine. | Neuropsychiatric disease and treatment 20071201 |
[The Vigimig study of naratriptan use in general practice]. | Presse medicale (Paris, France : 1983) 20071101 |
Serotonin, 5-HT 1B/1D receptor, agonists are effective in acute benign lymphocytic meningitis--a case report. | Cephalalgia : an international journal of headache 20071001 |
Parenteral vs. oral sumatriptan and naratriptan: plasma levels and efficacy in migraine. a comment. | The journal of headache and pain 20071001 |
Menstrually related migraine: breaking the cycle in your clinical practice. | The Journal of reproductive medicine 20071001 |
Economic analysis of triptan therapy for acute migraine: a Medicaid perspective. | Pharmacotherapy 20070801 |
Times to pain relief and pain freedom with rizatriptan 10 mg and other oral triptans. | International journal of clinical practice 20070701 |
Characterization of the human basilar artery contractile response to 5-HT and triptans. | Fundamental & clinical pharmacology 20070601 |
Glutamate levels in cerebrospinal fluid and triptans overuse in chronic migraine. | Headache 20070601 |
Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine. | Headache 20070601 |
Acute migraine: Current treatment and emerging therapies. | Therapeutics and clinical risk management 20070601 |
[Naratriptan. A new medical option for the pharmacist]. | Medizinische Monatsschrift fur Pharmazeuten 20070501 |
Use of the sustained pain-free plus no adverse events endpoint in clinical trials of triptans in acute migraine. | CNS drugs 20070101 |
Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies. | Headache 20070101 |
Over-the-counter triptans for migraine : what are the implications? | CNS drugs 20070101 |
[Prophylactic measures and acute treatment of migraine]. | Schmerz (Berlin, Germany) 20061101 |
A review of evidence-based medicine and meta-analytic reviews in migraine. | Cephalalgia : an international journal of headache 20061101 |
A model-based approach to treatment comparison in acute migraine. | British journal of clinical pharmacology 20061101 |
Tailoring management strategies for the patient with menstrual migraine: focus on prevention and treatment. | Headache 20061001 |
Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? | Neurobiology of disease 20060901 |
Frovatriptan: a review of pharmacology, pharmacokinetics and clinical potential in the treatment of menstrual migraine. | Therapeutics and clinical risk management 20060901 |
Rizatriptan in the treatment of migraine. | Neuropsychiatric disease and treatment 20060901 |
Prophylaxis of migraine. | Neuropsychiatric disease and treatment 20060901 |
Infrequent or non-response to oral sumatriptan does not predict response to other triptans--review of four trials. | Cephalalgia : an international journal of headache 20060201 |
[Medical treatment of migraine attacks in the child]. | Revue de l'infirmiere 20060101 |
Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons. | Molecular pain 20060101 |
Eletriptan: a review of its use in the acute treatment of migraine. | Drugs 20060101 |
[Clinical use of triptans in the management of migraine]. | CNS drugs 20060101 |
Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy. | American journal of therapeutics 20060101 |
Spotlight on eletriptan in migraine. | CNS drugs 20060101 |
A comparative study on the cost of new antibiotics and drugs of other therapeutic categories. | PloS one 20060101 |
Uncertainty analysis in pharmacokinetics and pharmacodynamics: application to naratriptan. | Pharmaceutical research 20051001 |
Efficacy of oral naratriptan in the treatment of menstrually related migraine. | European journal of neurology 20051001 |
[The role of triptans and analgesics for primary headache treatment]. | Nihon rinsho. Japanese journal of clinical medicine 20051001 |
The use of multiattribute decision models in evaluating triptan treatment options in migraine. | Journal of neurology 20050901 |
Triptans for migraine therapy: a comparison based on number needed to treat and doses needed to treat. | Journal of managed care pharmacy : JMCP 20050601 |
The combination of naratriptan and prochlorperazine in migraine treatment. | Headache 20050601 |
Prediction of genotoxicity of chemical compounds by statistical learning methods. | Chemical research in toxicology 20050601 |
Reinforced spatial alternation as an animal model of obsessive-compulsive disorder (OCD): investigation of 5-HT2C and 5-HT1D receptor involvement in OCD pathophysiology. | Biological psychiatry 20050515 |
Triptans induce vasoconstriction of human arteries and veins from the thoracic wall. | Journal of cardiovascular pharmacology 20050501 |
Advanced strategies of short-term prophylaxis in menstrual migraine: state of the art and prospects. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501 |
Naratriptan in the short-term prophylaxis of pure menstrual migraine. | Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 20050501 |
[Economic evaluation of acute migraine attack treatment with triptans in Spain]. | Neurologia (Barcelona, Spain) 20050401 |
Ischemic colitis associated with naratriptan and oral contraceptive use. | Headache 20050401 |
Eletriptan review. | Expert opinion on pharmacotherapy 20050401 |
[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties. | Naunyn-Schmiedeberg's archives of pharmacology 20050301 |
Correlation between lipophilicity and triptan outcomes. | Headache 20050101 |
An economic evaluation of rizatriptan in the treatment of migraine. | PharmacoEconomics 20050101 |
[Probabilistic cost-effectiveness analysis of oral eletriptan in the treatment of acute migraine in Portugal]. | Acta medica portuguesa 20050101 |
The use of triptans in the management of menstrual migraine. | CNS drugs 20050101 |
Naratriptan in the preventive treatment of refractory transformed migraine: a prospective pilot study. | Headache 20050101 |
Ischemic colitis associated with naratriptan and oral contraceptive use: a response. | Headache 20050101 |
Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine. | PharmacoEconomics 20050101 |
Preclinical neuropharmacology of naratriptan. | CNS drug reviews 20050101 |
Colonic ischemia associated with naratriptan use. | Journal of clinical gastroenterology 20041001 |
Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. | Annals of neurology 20040901 |
[Meta-analysis of triptan treatment in migraine]. | No to shinkei = Brain and nerve 20040901 |
Involvement of 5-HT1B receptors in triptan-induced contractile responses in guinea-pig isolated iliac artery. | Naunyn-Schmiedeberg's archives of pharmacology 20040701 |
The sumatriptan/naratriptan aggregated patient (SNAP) database: aggregation, validation and application. | Cephalalgia : an international journal of headache 20040701 |
Triptans and CNS side-effects: pharmacokinetic and metabolic mechanisms. | Cephalalgia : an international journal of headache 20040601 |
Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes. | Cephalalgia : an international journal of headache 20040601 |
Migraine headache. | Clinical evidence 20040601 |
Cost considerations of acute migraine treatment. | Headache 20040301 |
The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat. | Brain research 20040213 |
[Recent progress in therapy for migraine headache]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20040210 |
Naratriptan has a selective inhibitory effect on trigeminovascular neurones at central 5-HT1A and 5-HT(1B/1D) receptors in the cat: implications for migraine therapy. | Cephalalgia : an international journal of headache 20040201 |
Naratriptan for the treatment of acute migraine: meta-analysis of randomised controlled trials. | Pharmacoepidemiology and drug safety 20040201 |
Triptans and gastric accommodation: pharmacological and therapeutic aspects. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20040101 |
Patterns of use of triptans and reasons for switching them in a tertiary care migraine population. | Headache 20040101 |
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine. | BMC neurology 20040101 |
Efficacy of quality criteria to identify potentially harmful information: a cross-sectional survey of complementary and alternative medicine web sites. | Journal of medical Internet research 20040101 |
[Treatment of migraine]. | Medicinski arhiv 20040101 |
Comparative efficacy of eletriptan and zolmitriptan in the acute treatment of migraine. | Cephalalgia : an international journal of headache 20031201 |
Out-patient detoxification in chronic migraine: comparison of strategies. | Cephalalgia : an international journal of headache 20031201 |
Migraine headache. | Clinical evidence 20031201 |
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. | Cephalalgia : an international journal of headache 20031101 |
Investigation of the effects of naratriptan, rizatriptan, and sumatriptan on jugular venous oxygen saturation in anesthetized pigs: implications for their mechanism of acute antimigraine action. | The Journal of pharmacology and experimental therapeutics 20031001 |
Managing intractable migraine with naratriptan. | Headache 20031001 |
Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study. | Headache 20030901 |
Eletriptan metabolism by human hepatic CYP450 enzymes and transport by human P-glycoprotein. | Drug metabolism and disposition: the biological fate of chemicals 20030701 |
S+ -flurbiprofen but not 5-HT1 agonists suppress basal and stimulated CGRP and PGE2 release from isolated rat dura mater. | Pain 20030601 |
[Improved pharmacokinetics. Fast tryptan with sustained response]. | MMW Fortschritte der Medizin 20030526 |
[Highly selective beginning. Associated symptoms and side effects in retrospect]. | MMW Fortschritte der Medizin 20030526 |
Demographic and migraine characteristics of adolescents with migraine: Glaxo Wellcome clinical trials' database. | Headache 20030501 |
Naratriptan in the preventive treatment of refractory chronic migraine: a review of 27 cases. | Headache 20030501 |
[A descriptive analysis of naratriptan use among migraineurs in ambulatory medicine]. | Revue neurologique 20030501 |
Safety profile of the triptans. | Expert opinion on drug safety 20030301 |
Migraine: pathophysiology, pharmacology, treatment and future trends. | Current vascular pharmacology 20030301 |
[Early, but not unnecessarily frequent administration. What is proper timing for triptan drugs?]. | MMW Fortschritte der Medizin 20030116 |
Pharmacological approaches to migraine. | Journal of neural transmission. Supplementum 20030101 |
Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. | Headache 20030101 |
Migraine: diagnosis and management. | Internal medicine journal 20030101 |
Newer formulations of the triptans: advances in migraine management. | Drugs 20030101 |
Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours. | Journal of managed care pharmacy : JMCP 20030101 |
Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. | Neuroscience 20030101 |
Naratriptan in the preventive treatment of cluster headache. | Cephalalgia : an international journal of headache 20021201 |
[Ischemic colitis associated with naratriptan administration]. | Gastroenterologie clinique et biologique 20021101 |
Gateways to clinical trials. | Methods and findings in experimental and clinical pharmacology 20021101 |
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. | Cephalalgia : an international journal of headache 20021001 |
Triptans reduce the inflammatory response in bacterial meningitis. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20020801 |
Selegiline: a second look. Six years later: too risky in Parkinson's disease. | Prescrire international 20020801 |
Mechanisms of action of the 5-HT1B/1D receptor agonists. | Archives of neurology 20020701 |
Pharmacological treatments for acute migraine: quantitative systematic review. | Pain 20020601 |
Gateways to Clinical Trials. June 2002. | Methods and findings in experimental and clinical pharmacology 20020601 |
Agonist-directed trafficking explaining the difference between response pattern of naratriptan and sumatriptan in rabbit common carotid artery. | British journal of pharmacology 20020501 |
Gateways to Clinical Trials. | Methods and findings in experimental and clinical pharmacology 20020401 |
The role of 5-HT1B and 5-HT1D receptors in the selective inhibitory effect of naratriptan on trigeminovascular neurons. | Neuropharmacology 20020301 |
Migraine: diagnosis, management, and new treatment options. | The American journal of managed care 20020201 |
Comparison of triptan tablet consumption per attack: a prospective study of migraineurs in Spain. | Headache 20020201 |
Health needs, drug registration and control in less developed countries--the Peruvian case. | Pharmacoepidemiology and drug safety 20020101 |
Naratriptan in the prophylaxis of cluster headache. | Headache 20020101 |
Rizatriptan: an update of its use in the management of migraine. | Drugs 20020101 |
Validation of the Patient Perception of Migraine Questionnaire. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20020101 |
Spotlight on rizatriptan in migraine. | CNS drugs 20020101 |
Restoring migraine sufferers' ability to function normally: a comparison of rizatriptan and other triptans in randomized trials. | European neurology 20020101 |
An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. | Proceedings of the Western Pharmacology Society 20020101 |
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. | Lancet (London, England) 20011117 |
Clinical features of withdrawal headache following overuse of triptans and other headache drugs. | Neurology 20011113 |
[Cost effectiveness of treatment with triptanes in Spain]. | Revista de neurologia 20011101 |
Comparison of rizatriptan and other triptans on stringent measures of efficacy. | Neurology 20011023 |
Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons. | International journal of clinical practice 20011001 |
Advances in pharmacological treatment of migraine. | Expert opinion on investigational drugs 20011001 |
Have the triptans fulfilled their promise? | Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 20010901 |
Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. | Headache 20010901 |
Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan. | Pharmaceutical research 20010801 |
Establishing a standard of speed for assessing the efficacy of the serotonin(1B/1D) agonists (triptans). | Archives of neurology 20010701 |
Intranasal absorption of sumatriptan and naratriptan: no evidence of local transfer from the nasal cavities to the brain arterial blood in male rats. | Biopharmaceutics & drug disposition 20010701 |
Headache and female hormones: what you need to know. | Current opinion in neurology 20010601 |
Current options for the prevention and treatment of migraine. | Clinical therapeutics 20010601 |
Migraine treatment outcomes with rizatriptan in triptan-naive patients: a naturalistic study. | Clinical therapeutics 20010601 |
Treatment of migraine in Canada with naratriptan: a cost-effectiveness analysis. | Headache 20010501 |
[Current topics: expectation for new triptans]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20010410 |
Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. | Headache 20010301 |
Gastric motor effects of triptans: open questions and future perspectives. | Pharmacological research 20010301 |
Donitriptan (Pierre Fabre). | Current opinion in investigational drugs (London, England : 2000) 20010301 |
Acute treatment of migraine and the role of triptans. | Current neurology and neuroscience reports 20010301 |
Modulation of neuronal activity in the nucleus raphé magnus by the 5-HT(1)-receptor agonist naratriptan in rat. | Pain 20010215 |
Pharmacokinetics of naratriptan in adolescent subjects with a history of migraine. | Journal of clinical pharmacology 20010201 |
A systematic review of the use of triptans in acute migraine. | The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 20010201 |
Naratriptan prophylactic treatment in cluster headache. | Cephalalgia : an international journal of headache 20010201 |
New abortive agents for the treatment of migraine. | Advances in internal medicine 20010101 |
Pharmacokinetics and pharmacodynamics of the triptan antimigraine agents: a comparative review. | Clinical pharmacokinetics 20010101 |
Sumatriptan and naratriptan tolerability and safety: an update of post-marketing experience. | Cephalalgia : an international journal of headache 20010101 |
Building on the sumatriptan experience: the development of naratriptan. | Cephalalgia : an international journal of headache 20010101 |
Looking forward: the expanding utility of sumatriptan and naratriptan. | Cephalalgia : an international journal of headache 20010101 |
Sumatriptan: pharmacological basis and clinical results. | Current medical research and opinion 20010101 |
Naratriptan. | Current medical research and opinion 20010101 |
Comparative aspects of triptans in treating migraine. | Clinical cornerstone 20010101 |
[Quality of life of migraine patients after treatment with 2.5 mg oral naratriptan]. | Presse medicale (Paris, France : 1983) 20001209 |
Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? | Cephalalgia : an international journal of headache 20001001 |
Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients. Naratriptan International Recurrence Study Group. | Clinical therapeutics 20000801 |
Low migraine headache recurrence with naratriptan: clinical parameters related to recurrence. | Headache 20000201 |
Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents. | Acta neurologica Belgica 19990601 |
Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors. | European journal of pharmacology 19990305 |
N-Methyl-5-tert-butyltryptamine: A novel, highly potent 5-HT1D receptor agonist. | Journal of medicinal chemistry 19990211 |
Coronary side-effect potential of current and prospective antimigraine drugs. | Circulation 19980707 |
Characterization of human serotonin 1D and 1B receptors using [3H]-GR-125743, a novel radiolabelled serotonin 5HT1D/1B receptor antagonist. | Naunyn-Schmiedeberg's archives of pharmacology 19970901 |
Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy. | Naunyn-Schmiedeberg's archives of pharmacology 19970601 |
Naratriptan: biological profile in animal models relevant to migraine. | Cephalalgia : an international journal of headache 19970501 |
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. | British journal of pharmacology 19950301 |
© 2019 Angene International Limited. All rights Reserved.